ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1
Vaughn DW, Hoke CH, 1992. The epidemiology of Japanese encephalitis: prospects for prevention. Epidemiol Rev 14 :197–221.
-
2
Halstead SB, Tsai TF, 2004. Japanese encephalitis vaccines. Plotkin SA, Orenstein WA, eds. Vaccines. Fourth edition. Philadelphia: WB Saunders, 919–958.
-
3
Tsai TF, 2000. New initiatives for the control of Japanese encephalitis by vaccination. Minutes of a WHO/CVI meeting, October 13–15, 1998, Bangkok, Thailand. Vaccine 18 (Suppl 2):1–25.
-
4
Solomon T, Dung NM, Kneen R, Gainsborough M, Vaughn DW, Khanh VT, 2000. Japanese encephalitis. J Neurol Neurosurg Psychiatry 68 :405–415.
-
5
Kalayanarooj S, 1995. Japanese encephalitis: Clinical manifestations, outcome and management. Southeast Asian J Trop Med Public Health 26 (Suppl 3):9.
-
6
Misra UK, Kalita J, 2002. Prognosis of Japanese encephalitis patients with dystonia compared to those with parkinsonian features only. Postgrad Med J 78 :238–241.
-
7
World Health Organization, Regional Office for South-East Asia, 2006. Vaccine Preventable Disease Surveillance Bulletin. New Delhi, India: WHO, 10(40).
-
8
Sabchareon A, Yoksan S, 1998. Japanese encephalitis. Ann Trop Paediatr 18 (Suppl):S67–S71.
-
9
Burke DS, Nisalak A, Ussery MA, Laorakpongse T, Chantavibul S, 1985. Kinetics of IgM and IgG responses to Japanese encephalitis virus in human serum and cerebrospinal fluid. J Infect Dis 151 :1093–1099.
-
10
Cuzzubbo AJ, Endy TP, Vaughn DW, Solomon T, Nisalak A, Kalayanarooj S, Dung NM, Warrilow D, Aaskov J, Devine PL, 1999. Evaluation of a new commercially available immunoglobulin M capture enzyme-linked immunosorbent assay for diagnosis of Japanese encephalitis infections. J Clin Microbiol 37 :3738–3741.
-
11
World Health Organization, 2005. Global measles and rubella laboratory network update. Wkly Epidemiol Rec 80 :384–388.
-
12
E-JED01C–Japanese encephalitis–Dengue IgM Combo website. Available at: http://www.panbio.com/modules.php?name=catalog&file=product_info&cPath=21&products_id=627. Accessed December 18, 2006.
-
13
JE DETECT IgM ELISA website. Available at: http://www.inbios.com/products.php?code=elisaJEM. Accessed December 18, 2006.
-
14
Hunt AR, Cropp CB, Chang GJ, 2001. A recombinant particulate antigen of Japanese encephalitis virus produced in stably-transformed cells is an effective noninfectious antigen and subunit immunogen. J Virol Methods 97 :133–149.
-
15
Ravi V, Desai A, Balaji M, Apte MP, Lakshman L, Subbakrishna DK, Sridharan G, Dhole TN, Ravikumar BV, 2006. Development and evaluation of a rapid IgM capture ELISA (JEV-Chex) for the diagnosis of Japanese encephalitis. J Clin Virol 35 :429–434.
-
16
Burke DS, Nisalak A, 1982. Detection of Japanese encephalitis virus immunoglobulin M antibodies in serum by antibody capture radioimmunoassay. J Clin Microbiol 15 :353–361.
-
17
Burke DS, Nisalak A, Ussery MA, 1982. Antibody capture immunoassay detection of Japanese encephalitis virus immunoglobulin M and G antibodies in cerebrospinal fluid. J Clin Microbiol 16 :1034–1042.
-
18
World Health Organization, 2006. WHO-Recommended Standards for Surveillance of Selected Vaccine-Preventable Diseases. WHO/V&B/03.01. Geneva, Switzerland: World Health Organization.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 1212 | 1125 | 384 |
| Full Text Views | 121 | 13 | 0 |
| PDF Downloads | 42 | 11 | 0 |
Evaluation of Three Immunoglobulin M Antibody Capture Enzyme-linked Immunosorbent Assays for Diagnosis of Japanese Encephalitis
Julie A. Jacobson
Julie A. Jacobson
Japanese Encephalitis Project, PATH, Seattle, Washington; Department of Virology, United States Army Medical Component -Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand; Division of Global Migration and Quarantine, Centers for Disease Control and Prevention, Seattle, Washington
Search for other papers by Julie A. Jacobson in
Current site
Google Scholar
PubMed
Search for other papers by Julie A. Jacobson in
Current site
Google Scholar
PubMed
Susan L. Hills
Susan L. Hills
Japanese Encephalitis Project, PATH, Seattle, Washington; Department of Virology, United States Army Medical Component -Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand; Division of Global Migration and Quarantine, Centers for Disease Control and Prevention, Seattle, Washington
Search for other papers by Susan L. Hills in
Current site
Google Scholar
PubMed
Search for other papers by Susan L. Hills in
Current site
Google Scholar
PubMed
Jennifer L. Winkler
Jennifer L. Winkler
Japanese Encephalitis Project, PATH, Seattle, Washington; Department of Virology, United States Army Medical Component -Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand; Division of Global Migration and Quarantine, Centers for Disease Control and Prevention, Seattle, Washington
Search for other papers by Jennifer L. Winkler in
Current site
Google Scholar
PubMed
Search for other papers by Jennifer L. Winkler in
Current site
Google Scholar
PubMed
Mammen Mammen
Mammen Mammen
Japanese Encephalitis Project, PATH, Seattle, Washington; Department of Virology, United States Army Medical Component -Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand; Division of Global Migration and Quarantine, Centers for Disease Control and Prevention, Seattle, Washington
Search for other papers by Mammen Mammen in
Current site
Google Scholar
PubMed
Search for other papers by Mammen Mammen in
Current site
Google Scholar
PubMed
Butsaya Thaisomboonsuk
Butsaya Thaisomboonsuk
Japanese Encephalitis Project, PATH, Seattle, Washington; Department of Virology, United States Army Medical Component -Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand; Division of Global Migration and Quarantine, Centers for Disease Control and Prevention, Seattle, Washington
Search for other papers by Butsaya Thaisomboonsuk in
Current site
Google Scholar
PubMed
Search for other papers by Butsaya Thaisomboonsuk in
Current site
Google Scholar
PubMed
Anthony A. Marfin
Anthony A. Marfin
Japanese Encephalitis Project, PATH, Seattle, Washington; Department of Virology, United States Army Medical Component -Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand; Division of Global Migration and Quarantine, Centers for Disease Control and Prevention, Seattle, Washington
Search for other papers by Anthony A. Marfin in
Current site
Google Scholar
PubMed
Search for other papers by Anthony A. Marfin in
Current site
Google Scholar
PubMed
Robert V. Gibbons
Robert V. Gibbons
Japanese Encephalitis Project, PATH, Seattle, Washington; Department of Virology, United States Army Medical Component -Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand; Division of Global Migration and Quarantine, Centers for Disease Control and Prevention, Seattle, Washington
Search for other papers by Robert V. Gibbons in
Current site
Google Scholar
PubMed
Search for other papers by Robert V. Gibbons in
Current site
Google Scholar
PubMed
Japanese encephalitis (JE) virus is a major cause of neurologic infection in Asia, but surveillance has been limited. Three JE immunoglobulin M (IgM) antibody capture enzyme-linked immunosorbent assay kits have recently been developed. The aim of this study was to evaluate their sensitivity, specificity, and usability using 360 acute-phase serum samples containing JE, dengue, or neither IgM antibody. The kits, manufactured by Panbio Limited, Inbios International, Inc., and XCyton Diagnostics Ltd, had high sensitivities of 89.3%, 99.2%, and 96.7%, respectively. The specificities were 99.2%, 56.1%, and 65.3%, respectively. When dengue IgM-positive samples were excluded, the kits had specificities of 98.4%, 96.1%, and 96.1%, respectively. The Panbio kit includes both JE and dengue antigens and appears to have an advantage in settings where dengue virus co-circulates, although further assessments in clinical settings are needed. This information is helpful in considering options for strengthening the laboratory component of JE surveillance.
Author Notes
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1
Vaughn DW, Hoke CH, 1992. The epidemiology of Japanese encephalitis: prospects for prevention. Epidemiol Rev 14 :197–221.
-
2
Halstead SB, Tsai TF, 2004. Japanese encephalitis vaccines. Plotkin SA, Orenstein WA, eds. Vaccines. Fourth edition. Philadelphia: WB Saunders, 919–958.
-
3
Tsai TF, 2000. New initiatives for the control of Japanese encephalitis by vaccination. Minutes of a WHO/CVI meeting, October 13–15, 1998, Bangkok, Thailand. Vaccine 18 (Suppl 2):1–25.
-
4
Solomon T, Dung NM, Kneen R, Gainsborough M, Vaughn DW, Khanh VT, 2000. Japanese encephalitis. J Neurol Neurosurg Psychiatry 68 :405–415.
-
5
Kalayanarooj S, 1995. Japanese encephalitis: Clinical manifestations, outcome and management. Southeast Asian J Trop Med Public Health 26 (Suppl 3):9.
-
6
Misra UK, Kalita J, 2002. Prognosis of Japanese encephalitis patients with dystonia compared to those with parkinsonian features only. Postgrad Med J 78 :238–241.
-
7
World Health Organization, Regional Office for South-East Asia, 2006. Vaccine Preventable Disease Surveillance Bulletin. New Delhi, India: WHO, 10(40).
-
8
Sabchareon A, Yoksan S, 1998. Japanese encephalitis. Ann Trop Paediatr 18 (Suppl):S67–S71.
-
9
Burke DS, Nisalak A, Ussery MA, Laorakpongse T, Chantavibul S, 1985. Kinetics of IgM and IgG responses to Japanese encephalitis virus in human serum and cerebrospinal fluid. J Infect Dis 151 :1093–1099.
-
10
Cuzzubbo AJ, Endy TP, Vaughn DW, Solomon T, Nisalak A, Kalayanarooj S, Dung NM, Warrilow D, Aaskov J, Devine PL, 1999. Evaluation of a new commercially available immunoglobulin M capture enzyme-linked immunosorbent assay for diagnosis of Japanese encephalitis infections. J Clin Microbiol 37 :3738–3741.
-
11
World Health Organization, 2005. Global measles and rubella laboratory network update. Wkly Epidemiol Rec 80 :384–388.
-
12
E-JED01C–Japanese encephalitis–Dengue IgM Combo website. Available at: http://www.panbio.com/modules.php?name=catalog&file=product_info&cPath=21&products_id=627. Accessed December 18, 2006.
-
13
JE DETECT IgM ELISA website. Available at: http://www.inbios.com/products.php?code=elisaJEM. Accessed December 18, 2006.
-
14
Hunt AR, Cropp CB, Chang GJ, 2001. A recombinant particulate antigen of Japanese encephalitis virus produced in stably-transformed cells is an effective noninfectious antigen and subunit immunogen. J Virol Methods 97 :133–149.
-
15
Ravi V, Desai A, Balaji M, Apte MP, Lakshman L, Subbakrishna DK, Sridharan G, Dhole TN, Ravikumar BV, 2006. Development and evaluation of a rapid IgM capture ELISA (JEV-Chex) for the diagnosis of Japanese encephalitis. J Clin Virol 35 :429–434.
-
16
Burke DS, Nisalak A, 1982. Detection of Japanese encephalitis virus immunoglobulin M antibodies in serum by antibody capture radioimmunoassay. J Clin Microbiol 15 :353–361.
-
17
Burke DS, Nisalak A, Ussery MA, 1982. Antibody capture immunoassay detection of Japanese encephalitis virus immunoglobulin M and G antibodies in cerebrospinal fluid. J Clin Microbiol 16 :1034–1042.
-
18
World Health Organization, 2006. WHO-Recommended Standards for Surveillance of Selected Vaccine-Preventable Diseases. WHO/V&B/03.01. Geneva, Switzerland: World Health Organization.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 1212 | 1125 | 384 |
| Full Text Views | 121 | 13 | 0 |
| PDF Downloads | 42 | 11 | 0 |